In the Orphan Drug Approval Race, Winner Takes All? Ramifications of Catalyst Pharms. v. Becerra

October 11, 2021

GSK v. Teva: Federal Circuit Issues New Opinion Analyzing Induced Infringement

August 20, 2021

President Biden’s Executive Order on Competition Signals Potential Changes Affecting Patents in the Healthcare Sector

July 30, 2021

President Biden’s Executive Order on Competition Signals Potential Changes Affecting Patents in the Healthcare Sector

July 28, 2021

“Advancing Education on Biosimilars”: Game Changer or More of the Same?

May 26, 2021

When Is Less Really More for a Patent Licensee?

May 14, 2021

When Is Less Really More for a Patent Licensee?

May 13, 2021

Induced Infringement of Method of Treatment Claims: Looking to the Label and Beyond

May 5, 2021

CAFC Tightens Enablement Standard for Functional Claiming of Antibodies

March 15, 2021